These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The long-acting thyroid stimulatory: is it of importance in Graves' disease. McKenzie JM; Zakarija M; D'Amour P; Joasoo A N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442 [No Abstract] [Full Text] [Related]
3. Reduced sensitivity of the thyroid to thyrotrophic hormone and LATS following treatment with antimicrosomal antibodies. Földes J; Takó J; Bános C; Gesztesi E; Juhász J Acta Endocrinol (Copenh); 1973 Dec; 74(4):675-84. PubMed ID: 4800904 [No Abstract] [Full Text] [Related]
4. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre. Stewart RD N Z Med J; 1975 Jan; 81(531):24. PubMed ID: 1055311 [No Abstract] [Full Text] [Related]
5. In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. Field JB; Remer A; Bloom G; Kriss JP J Clin Invest; 1968 Jul; 47(7):1553-60. PubMed ID: 5658587 [TBL] [Abstract][Full Text] [Related]
6. [Hyperthyroidism and the "long acting thyroid stimulator" (LATS)]. Studer H Schweiz Med Wochenschr; 1967 May; 97(19):622-3. PubMed ID: 5632362 [No Abstract] [Full Text] [Related]
8. [New ideas on the regulation of thyroid function by LATS (long-acting thyroid stimulator) and their repercussion on human pathology]. Strumia E Minerva Med; 1967 Nov; 58(90):3879-85. PubMed ID: 5630606 [No Abstract] [Full Text] [Related]
10. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results]. Busnardo B; Accordi F; Debiasi S Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578 [No Abstract] [Full Text] [Related]
11. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases]. Depisch D; Höfer R; Schatz H Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238 [No Abstract] [Full Text] [Related]
12. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism]. Lamberg BA; Gordin A Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398 [No Abstract] [Full Text] [Related]
13. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity. Kendall-Taylor P Br Med J; 1973 Jul; 3(5871):72-5. PubMed ID: 4740444 [TBL] [Abstract][Full Text] [Related]
14. Observations on the nature and significance of the long-acting thyroid stimulator. Brown J; Dorrington KJ; Ensor J; Smith BR; Munro DS Proc R Soc Med; 1968 Dec; 61(12):1301-2. PubMed ID: 4177972 [No Abstract] [Full Text] [Related]
15. [LATS and Graves' disease]. Gordon A Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988 [No Abstract] [Full Text] [Related]
16. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease]. Orgiazzi J; Pousset G; Durand H Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634 [No Abstract] [Full Text] [Related]